Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.03.29
关于受让控股子公司股权的通告
2016.03.17
关于对外投资的希望通告
2016.03.12
关于回购部分社会公众股占公司总股本比例抵达2%的通告
2016.03.05
关于对外投资的希望通告
2016.03.02
关于公司使用自有资金购置低危害理工业品的希望通告
2016.03.02
关于回购部分社会公众股份的希望通告
2016.02.20
2015年度业绩快报
2016.02.20
关于2015年度利润分派预案的预披露通告
2016.02.06
关于公司使用自有资金购置低危害理工业品的希望通告
2016.02.03
关于对全资子公司增资并加入投资设立医疗基金的希望通告
第一页
上一页
88
89
90
91
92
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】